Clinical trial
A Randomized Controlled Trial on the Role of Magnetic Resonance Imaging for Prostate Cancer Screening
NCT04803188 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial on the Role of Magnetic Resonance Imaging for Prostate Cancer Screening
- Lead sponsor
- University of Roma La Sapienza
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 21, 2020
- Completion date
- September 30, 2022
- Enrollment
- 710 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer (diagnosis)